Other Species / Isoforms
  CDH5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N61
MHIDEEKNtsLPHHV
0 1
CDH5 (human) MHIDEEKNtsLPHHV N61
CDH5 (mouse) MHIDEEKnESLPHYV N59-ng
CDH5 (rat) MHIDEEKNESLPHYV N51
T62-p
HIDEEKNtsLPHHVG
0 1
CDH5 (human) HIDEEKNtsLPHHVG T62-p
CDH5 (mouse) HIDEEKnESLPHYVG E60
CDH5 (rat) HIDEEKNESLPHYVG E52
S63-p
IDEEKNtsLPHHVGK
0 1
CDH5 (human) IDEEKNtsLPHHVGK S63-p
CDH5 (mouse) IDEEKnESLPHYVGK S61
CDH5 (rat) IDEEKNESLPHYVGK S53
Y82-p
VSRKNAKyLLKGEYV
0 1
CDH5 (human) VSRKNAKyLLKGEYV Y82-p
CDH5 (mouse) VNRQNAKYVLQGEFA Y80
CDH5 (rat) VNRQNAKYVLQGEQA Y72
N157
VFTHRLFNASVPESS
0 1
CDH5 (human) VFTHRLFNASVPESS N157
CDH5 (mouse) VFSHQVFnASVPEMS N155-ng
CDH5 (rat) VFTHQVFNASVPEMS N147
T212-p
SGRIITItKSLDREK
0 1
CDH5 (human) SGRIITItKSLDREK T212-p
CDH5 (mouse) SGLIFTKIKNLDREK I210
CDH5 (rat) SGLIFTKDKNLDRET D202
Y223-p
DREKQARyEIVVEAR
0 1
CDH5 (human) DREKQARyEIVVEAR Y223-p
CDH5 (mouse) DREKQAEYKIVVETQ Y221
CDH5 (rat) DRETRAEYKIVVEAQ Y213
Y295
PQNRMTKYSILRGDY
0 1
CDH5 (human) PQNRMTKYSILRGDY Y295
CDH5 (mouse) PQNRMTKysIMQGEY Y293-p
CDH5 (rat) PQNRMTKYSIMQGEY Y285
S296
QNRMTKYSILRGDYQ
0 1
CDH5 (human) QNRMTKYSILRGDYQ S296
CDH5 (mouse) QNRMTKysIMQGEYR S294-p
CDH5 (rat) QNRMTKYSIMQGEYR S286
M322
NEGIIKPMKPLDYEY
0 1
CDH5 (human) NEGIIKPMKPLDYEY M322
CDH5 (mouse) NEGIIKPtKSLDYEV T320-p
CDH5 (rat) NEGIIKPTKPLDYEL T312
T392-p
QKKPLIGtVLAMDPD
Upstream
0 2
Treatment
  • JAK_inhibitor_I
CDH5 (human) QKKPLIGtVLAMDPD T392-p
CDH5 (mouse) QKKPLIGTVVAKDPD T391
CDH5 (rat) KKKPLIGTVVAKDPD T383
N442
REVYPWYNLTVEAKE
0 1
CDH5 (human) REVYPWYNLTVEAKE N442
CDH5 (mouse) RETYAWYnLTVEANE N441-ng
CDH5 (rat) RETHAWYNLTVEANE N433
N523
FILNTENNFTLTDNH
0 1
CDH5 (human) FILNTENNFTLTDNH N523
CDH5 (mouse) ALKNEDSnFTLINNH N523-ng
CDH5 (rat) ALKNEDSNFTLINNH N515
N535
DNHDNTANITVKYGQ
0 1
CDH5 (human) DNHDNTANITVKYGQ N535
CDH5 (mouse) NNHDNTAnITVKYGQ N535-ng
CDH5 (rat) NNHDNTANITVKYGQ N527
Y645
IHEQLVTYDEEGGGE
1 0
CDH5 (human) IHEQLVTYDEEGGGE Y645
CDH5 (mouse) IHEQLVTyDEEGGGE Y645-p
CDH5 (rat) IHEQLVTYDEEGGGE Y637
Y658-p
GEMDTTSyDVSVLNs
Upstream
Downstream
8 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell adhesion, altered
  • cell motility, altered
  • cell motility, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • Src (human)
Regulatory protein:
  • BRAF (human)
  • CD44 (human)
  • F3 (human)
  • RRas (human)
Treatment
  • chondroitinase AC
  • culturing_of_cells
  • hirudin
  • neuraminidase
  • platlet-free_plasma
  • vanadate
  • VEGF
CDH5 (human) GEMDTTSyDVSVLNs Y658-p
CDH5 (mouse) GEMDTTSyDVSVLNs Y658-p
CDH5 (rat) GEMDTTSYDVSVLNS Y650
S665-p
yDVSVLNsVRRGGAK
Upstream
Downstream
3 0
Effects on Modified Protein
  • intracellular localization
Regulatory protein:
  • RRas (human)
Treatment
  • angiopoietin-1
  • VEGF
CDH5 (human) yDVSVLNsVRRGGAK S665-p
CDH5 (mouse) yDVSVLNsVRGGSTK S665-p
CDH5 (rat) YDVSVLNSVRTGSNK S657
S683-p
PALDARPsLyAQVQK
0 4
CDH5 (human) PALDARPsLyAQVQK S683-p
CDH5 (mouse) STMDARPAVyTQVQk A683
CDH5 (rat) STMDARPAVyTQVQK A675
Y685-p
LDARPsLyAQVQKPP
Upstream
Downstream
10 147
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
Regulatory protein:
  • BRAF (human)
  • F3 (human)
  • Src (human)
Treatment
  • AG490
  • hirudin
  • IL-6
  • LY294002
  • PD98059
  • platlet-free_plasma
  • PP2
  • SU6656
  • vanadate
  • VEGF
CDH5 (human) LDARPsLyAQVQKPP Y685-p
CDH5 (mouse) MDARPAVyTQVQkPP Y685-p
CDH5 (rat) MDARPAVyTQVQKPP Y677-p
K690
sLyAQVQKPPRHAPG
0 1
CDH5 (human) sLyAQVQKPPRHAPG K690
CDH5 (mouse) AVyTQVQkPPRLAPG K690-ub
CDH5 (rat) AVyTQVQKPPRLAPS K682
Y725-p
HDGDGPPyDTLHIyG
0 2
CDH5 (human) HDGDGPPyDTLHIyG Y725-p
CDH5 (mouse) NDGGGPPYDTLHIyG Y725
CDH5 (rat) NDGGGPPYDTLHIYG Y717
Y731-p
PyDTLHIyGyEGSES
Upstream
Downstream
10 1
Effects on Modified Protein
  • molecular association, regulation
Putative in vivo kinases:
  • Src (human)
Regulatory protein:
  • BRAF (human)
  • CD44 (human)
  • F3 (human)
  • RRas (human)
Treatment
  • ascorbic_acid
  • chondroitinase AC
  • culturing_of_cells
  • hirudin
  • neuraminidase
  • platlet-free_plasma
  • thrombin
  • vanadate
  • VEGF
CDH5 (human) PyDTLHIyGyEGSES Y731-p
CDH5 (mouse) PYDTLHIyGyEGAES Y731-p
CDH5 (rat) PYDTLHIYGYEGTES Y723
Y733-p
DTLHIyGyEGSESIA
1 1
CDH5 (human) DTLHIyGyEGSESIA Y733-p
CDH5 (mouse) DTLHIyGyEGAESIA Y733-p
CDH5 (rat) DTLHIYGYEGTESIA Y725
Y774-p
FKMLAELyGSDPREE
0 1
CDH5 (human) FKMLAELyGSDPREE Y774-p
CDH5 (mouse) FKMLAELYGSDPQEE Y774
CDH5 (rat) FKMLAELYGSDPQEE Y766
Y784-p
DPREELLy_______
0 1
CDH5 (human) DPREELLy_______ Y784-p
CDH5 (mouse) DPQEELII_______ I784
CDH5 (rat) DPQEELII_______ I776